Topical Steroid Withdrawal

LSPSPbanner

Topical Steroid Withdrawal

Topical steroid withdrawal is not fully understood as a syndrome.
 

Research overview

Topical corticosteroids are a common treatment for eczema. Whilst evidence suggests that they are generally effective and safe treatments for most people, there are some people who experience adverse reactions.

Topical steroid withdrawal is not fully understood as a syndrome, but the UK Medicines & Healthcare products Regulatory Agency (MHRA) have recognised that withdrawal reactions can occur if topical corticosteroids are “used very often or continually for a prolonged time”.

Due to the lack of good quality research on Topical Steroid Withdrawal and lack of consensus amongst healthcare professionals and organisations, patients who experience adverse reactions to topical corticosteroids often struggle to access appropriate support or recognition from the healthcare system.

Our team is committed to working with patients and healthcare professionals to deliver research to support people with Topical Steroid Withdrawal and people with concerns about using topical corticosteroids.

Ongoing projects

 

Navigating Primary Care with Topical Steroid Withdrawal

 

All projects

ProjectDescriptionFundingStatus

Navigating Primary Care with Topical Steroid Withdrawal

A qualitative study to understand the lived experiences of Topical Steroid Withdrawal and navigating primary care with Topical Steroid Withdrawal. We interviewed people who self-reported experiencing Topical Steroid Withdrawal and healthcare professionals to build a greater shared understanding about the nature and consequences of topical steroid withdrawal.

Relevant Publications:
Laura Howells, Holly Broome, Alice Burleigh, Harriet Hammond, Farhan Ismail, Andrew Proctor, Amanda Roberts, Kim S Thomas, Paul Leighton, Topical corticosteroid withdrawal syndrome: the patient community call for high-quality research, clear definitions and diagnostic criteria, British Journal of Dermatology, Volume 188, Issue 2, February 2023, Pages 288–289, https://doi.org/10.1093/bjd/ljac067

This project is conducted in partnership with TSW patient advocacy group Scratch That UK and patient charity the National Eczema Society.

In set-up

Centre of Evidence Based Dermatology

The University of Nottingham
Applied Health Research Building
University Park, Nottingham
NG7 2RD


telephone: +44 (0) 115 84 68631
email: cebd@nottingham.ac.uk